Activities, Bill Numbers and Titles
|
|
Client: Novo Nordisk Inc.
|
Total amount paid by client; lobbyist is unable to report compensation at activity level: $5,790.00
|
House Bill
|
1133
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1852
|
An Act relative to diabetes prevention
|
Support
|
$0.00
|
N/A
|
House Bill
|
1162
|
An Act to promote transparency in prescription drug prices
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
4132
|
An Act Making Appropriations for the Fiscal Year 2019 to Provide for Supplementing Certain Existing Appropriations and for Certain Other Activities and Projects
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
2378
|
An Act Making Appropriations for the Fiscal Year 2019 to Provide for Supplementing Certain Existing Appropriations and for Certain Other Activities and Projects
|
Support
|
$0.00
|
N/A
|
House Bill
|
1999
|
An Act creating an obesity task force and pilot program
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
721
|
An Act relative to mandatory prescription drug coverage
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
1148
|
An Act regarding Massachusetts drug price relief
|
Oppose
|
$0.00
|
N/A
|
House Bill
|
2209
|
An Act to provide diabetes prevention program benefits
|
Support
|
$0.00
|
N/A
|
Senate Bill
|
706
|
An Act to ensure prescription drug cost transparency and affordability
|
Oppose
|
$0.00
|
N/A
|
| | |
Total amount
|
$0.00
| |
|
|
|
Meals, Travel, and Entertainment Expenses
|
No meals, travel, or entertainment expenses were filed for this disclosure reporting period. |
|
|
Additional Expenses
|
No additional expenses were filed for this disclosure reporting period. |
|
|
Campaign Contributions
|
07/23/2019 |
Jennifer Benson
|
House, 37th Middlesex
|
$100.00
|
10/29/2019 |
Patrick O'Connor
|
Senate, Plymouth & Norfolk
|
$100.00
|
11/11/2019 |
Dan Cullinane
|
House, 12th Suffolk
|
$100.00
|
12/04/2019 |
Danielle Gregoire
|
House, 4th Middlesex
|
$100.00
|
| | Total contributions |
$400.00
|
|